Drug Target Review2025-04-11T08:30:52
Researchers at UTHealth Houston have initiated a new stem cell therapy trial aimed at reducing neuroinflammation to prevent Alzheimer's disease before symptoms emerge, an approach that could revolutionise treatment strategies, offering new hope for at-risk individuals.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2026-06-02T15:00:00
Sponsored by Danaher Life Sciences
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2026-05-19T09:46:00
Contributor Dr Nitza Thomasson
2024-01-10T08:23:16
Sponsored by BellBrook Labs
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud